Gene · 411
Papers1,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term temporal stability of circulating proteins in older adults. | bioRxiv | 2025 | 41278685 | PubTator, text mining | PubMed |
| Clinical and genetic characteristics of mucopolysaccharidosis type VI according to the Russian registry. | World J Clin Pediatr | 2025 | 41255673 | PubTator, text mining | PubMed |
| Prognostic modeling of early-onset nondistal gastric cancer identifies ARSB-PDCD1 ratio as an immune-related survival stratifier. | Front Immunol | 2025 | 41089703 | PubTator, text mining | PubMed |
| Mucopolysaccharidosis VI: Therapeutic strategies and perspectives. | Mol Genet Metab | 2025 | 41066830 | PubTator, text mining | PubMed |
| Bacterial interactions with arsenic: Metabolic pathways, resistance mechanisms, and bioremediation approaches. | Sci Total Environ | 2025 | 41043264 | PubTator, text mining | PubMed |
| Disease-linked regulatory DNA variants and homeostatic transcription factors in epidermis. | Nat Commun | 2025 | 40998781 | PubTator, text mining | PubMed |
| Insights into the Evolutionary and Ecological Roles of Bathyarchaeia in Arsenic Detoxification. | Environ Sci Technol | 2025 | 40921195 | PubTator, text mining | PubMed |
| Nucleotide- and metalloid-driven conformational changes in the arsenite efflux ATPase ArsA. | Proc Natl Acad Sci U S A | 2025 | 40880530 | PubTator, text mining | PubMed |
| Hand stiffness not only a rheumatological sign: A case of early onset mucolipidosis III-gamma with literature review. | Mol Genet Metab Rep | 2025 | 40838094 | PubTator, text mining | PubMed |
| Distinct bacterial community structures and arsenic biotransformation gene profiles in dust. | Front Microbiol | 2025 | 40809051 | PubTator, text mining | PubMed |
| Functional Analysis of Complex Structural and Splice-Altering Variants in the ARSB Gene Towards the Personalized Antisense-Based Therapy for Mucopolysaccharidosis Type VI Patients. | Hum Mutat | 2025 | 40677925 | PubTator, text mining | PubMed |
| Arylsulfatase B induces melanoma apoptosis by the ubiquitin ligase COP1. | J Biol Chem | 2025 | 40562100 | PubTator, text mining | PubMed |
| Exploring sphingolipid metabolism-related biomarkers for Parkinson's disease: a transcriptomic analysis. | Front Neurol | 2025 | 40534738 | PubTator, text mining | PubMed |
| Simultaneously disinfection of amoebae, endosymbiotic bacteria, and resistance genes using a novel two-electron water oxidation strategy. | Water Res | 2025 | 40449332 | PubTator, text mining | PubMed |
| Interactions of CFTR and Arylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase) in Prostate Carcinoma. | Int J Mol Sci | 2025 | 40362587 | PubTator, text mining | PubMed |
| Efficacy of different treatment strategies in patients with mucopolysaccharidosis: a systematic review and network meta-analysis of randomized controlled trials. | Orphanet J Rare Dis | 2025 | 40317013 | PubTator, text mining | PubMed |
| Antimicrobial effects, and selection for AMR by non-antibiotic drugs in a wastewater bacterial community. | Environ Int | 2025 | 40300499 | PubTator, text mining | PubMed |
| Enhancement of Sensitivity in Aggregation-Based Whole-Cell Arsenite Sensor Utilizing Arsenic Metabolism Regulation. | ACS Omega | 2025 | 40256515 | PubTator, text mining | PubMed |
| Exploring microbial diversity in relation to hydrological signatures and anthropic pressures in the Beauce Aquifer, France. | Sci Total Environ | 2025 | 40239499 | PubTator, text mining | PubMed |
| Microbial diversity and capacity for arsenic biogeochemical cycling in aquifers associated with thermal mobilization. | Sci Total Environ | 2025 | 40239498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/411/papers?page=2